Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
US Stock MarketDetailed Quotes
GRAL Grail
- 35.480
- +1.720+5.10%
Trading Apr 24 12:05 ET
1.20BMarket Cap-0.59P/E (TTM)
36.050High34.170Low396.34KVolume34.440Open33.760Pre Close14.00MTurnover3.48%Turnover RatioLossP/E (Static)33.90MShares63.99052wk High0.48P/B404.25MFloat Cap12.33052wk Low--Dividend TTM11.39MShs Float63.990Historical High--Div YieldTTM5.57%Amplitude12.330Historical Low35.317Avg Price1Lot Size
Grail News
New Analyst Forecast: $GRAL Given $32.0 Price Target
GRAIL to Present New Data on Galleri and Its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting
Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence
CCORF Initiates Grail(GRAL.US) With Buy Rating, Announces Target Price $32
This Cancer Test Could Become Routine -- and a Big Seller, Says Analyst -- Barrons.com
Express News | Canaccord Genuity Initiates Coverage On GRAIL With Buy Rating, Announces Price Target of $32
Canaccord Starts Grail With a Buy, Sees 'Solid Upside'
Grail Initiated With a Buy at Canaccord
GRAIL, Inc. (GRAL): A Bull Case Theory
This Family Spent Years Chasing the Holy Grail of a 100% Roth Retirement Portfolio -- WSJ
Jim Cramer Asks Trump To Take Stock As Markets Swing Again Ahead Of 'Liberation Day'
Longevity Medical Institute Integrates OncoSeek to Launch One of Mexico's Most Advanced Cancer Screening Programs
Jim Cramer: Healthpeak Properties Is A 'Reasonable' REIT, Recommends Buying This Health Care Stock
Cramer's Lighting Round: 'I Would Be a Buyer' of Grail
GRAIL Is Maintained at Equal-Weight by Morgan Stanley
GRAIL Analyst Ratings
Express News | Grail Inc : Morgan Stanley Raises Target Price to $20.00 From $16.00
GRAIL Inc. Hold Rating: Balancing Positive Developments With Near-Term Challenges
This Insider Has Just Sold Shares In GRAIL
Nasdaq Rally: Nvidia Among Winners in Index's Strongest Day in 4 Months
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
